The pathogenesis of various tau-related diseases, focusing on the phosphorylation and structural alterations of the tau protein, is anticipated to be a primary area of research in future, with an emphasis on AD as a central investigative focus. This evidence concerns the gene MAPT and Alzheimer disease.